Back to AQST
GOLDMAN SACHS GROUP INC → AQST
GOLDMAN SACHS GROUP INC AQST Position History
Aquestive Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$364K
Q2 2026
Peak value
$5.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $1.6M |
| Q2 2025 | $94K |
| Q3 2025 | $1.8M |
| Q3 2025 | $444K |
| Q4 2025 | $564K |
| Q4 2025 | $5.3M |
| Q4 2025 | $5.3M |
| Q4 2025 | $564K |
| Q1 2026 | $1.7M |
| Q1 2026 | $264K |
| Q2 2026 | $1.6M |
| Q2 2026 | $364K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $364K | 87.5K | — | — |
| Q2 2026 | $1.6M | 381.0K | — | — |
| Q1 2026 | $264K | 63.6K | — | — |
| Q1 2026 | $1.7M | 403.2K | — | — |
| Q4 2025 | $564K | 87.3K | — | — |
| Q4 2025 | $5.3M | 821.7K | — | — |
| Q4 2025 | $5.3M | 821.7K | — | — |
| Q4 2025 | $564K | 87.3K | — | — |
| Q3 2025 | $444K | 79.3K | — | — |
| Q3 2025 | $1.8M | 315.8K | — | — |
| Q2 2025 | $94K | 28.5K | — | — |
| Q2 2025 | $1.6M | 496.2K | — | — |